Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by NamDoo Kim
Development of Covalent Inhibitors That Can Overcome Resistance to First-Generation FGFR Kinase Inhibitors
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Related publications
Development of Selective Covalent Janus Kinase 3 Inhibitors
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Novel Third-Generation EGFR Tyrosine Kinase Inhibitors and Strategies to Overcome Therapeutic Resistance in Lung Cancer
Cancer Research
Cancer Research
Oncology
Resistance to PARP Inhibitors by SLFN11 Inactivation Can Be Overcome by ATR Inhibition
Oncotarget
Oncology
Transporter and Lysosomal Mediated (Multi)drug Resistance to Tyrosine Kinase Inhibitors and Potential Strategies to Overcome Resistance
Cancers
Cancer Research
Oncology
Conjugation of Cisplatin Analogues and Cyclooxygenase Inhibitors to Overcome Cisplatin Resistance
ChemMedChem
Organic Chemistry
Molecular Medicine
Pharmacology
Biochemistry
Toxicology
Drug Discovery
Pharmaceutics
Electrophilic Fragment-Based Design of Reversible Covalent Kinase Inhibitors
Journal of the American Chemical Society
Biochemistry
Colloid
Catalysis
Chemistry
Surface Chemistry
Overcoming Resistance to First/Second Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and ALK Inhibitors in Oncogene-Addicted Advanced Non-Small Cell Lung Cancer
Therapeutic Advances in Medical Oncology
Oncology
WZ4002, a Third-Generation EGFR Inhibitor, Can Overcome Anoikis Resistance in EGFR-mutant Lung Adenocarcinomas More Efficiently Than SRC Inhibitors
Laboratory Investigation
Forensic Medicine
Pathology
Cell Biology
Molecular Biology
Covalent JNK Inhibitors?
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
